Growing focus on developing alternatives to animal testing is driving revenue growth of the market.
Growing focus on developing alternatives to animal testing is driving revenue growth of the market
The global 3D cell culture market size reached USD 1,032.9 Million in 2020 and is expected to reach USD 3,319.43 Million in 2028 and register a CAGR of 15.8% over the forecast period, according to latest analysis by Reports and Data. The 3D cell culture market revenue growth is fueled by several factors including growing popularity of 3D cell culture models as effective alternative tools for in vivo testing, rapid development of automated large-scale cell culture systems, and increasing demand for organ transplantation. Additionally, the 3D cell culture models are advantageous in terms of enabling drug safety and efficacy assessment in a more in vivo–like context compared to traditional 2D cell cultures, which is further augmenting demand for 3D cell culture models, thus, contributing to revenue growth of the global market.
3D cell culture is an in-vitro technique wherein the cells can grow in an environment which is artificially created. This advanced cell culture technique aids in stimulating cell differentiation, proliferation, and migration by interacting with their 3D/three-dimensional surroundings as they would in the in-vivo environment. Therefore, due to the ability of mimicking structure, activity, and microenvironment of the in-vivo tissues, 3D cell culture technique is used in several applications, especially in the fields of drug screening, stem cell therapies, regenerative medicine, cancer research, and cell biology.
However, high cost of cell biology research and lack of infrastructure for 3D cell-based research are some factors expected to hamper the overall revenue growth of the market to a certain extent over the forecast period.
Access Free sample PDF Copy of the Report @ https://www.reportsanddata.com/sample-enquiry-form/3707
Some Key Highlights from the Report:
- Based on product, the scaffold-based platforms segment is expected to register robust revenue CAGR in the global market going ahead owing to its usage in altering the cell culture procedure, as it provides a surface on which the cells can easily impart 3D growth. Moreover, scaffolds are extensively used in drug discovery and cell expansion, due to the availability of a variety of materials and structural choices, which is another factor supporting the segment revenue growth.
- In terms of application, the cancer research segment is expected to account for largest revenue share in the global market during the forecast period due to rising advantages offered by 3D cell culture in cancer research including ease of altering cell proliferation, capturing phenotypic heterogeneity, and revealing realistic drug response.
- North America market is expected to dominate other regional markets in terms of revenue share during the forecast period. High revenue growth of this regional market can be attributed to several pharmaceutical and biotechnology companies using 3D culture technology in collaboration with renowned research institutes in order to develop regenerative medicines and to accelerate drug discovery & development.
- Leading companies operating in the market are Thermo Fisher Scientific (U.S.), Corning Incorporated (U.S.), Merck KGaA (Germany), Lonza AG (Switzerland), REPROCELL Incorporated (Japan), TissUse (Germany), InSphero (Switzerland), Synthecon (U.S.), 3D Biotek (U.S.), CN Bio (UK), Hamilton Company (U.S.), and MIMETAS (Netherlands).
Buy now your Exclusive copy of Report @ https://www.reportsanddata.com/checkout-form/3707
For the purpose of this report, Reports and Data has segmented the global 3D cell culture market on the basis of product, application, end use, and region:
Product Outlook (Revenue, USD Million, 2018 - 2028)
- Scaffold-based 3D Cell Cultures
- Hydrogels/ECM Analogs
- Solid Scaffolds
- Micropatterned Surfaces
- Scaffold-free 3D Cell Cultures
- Low Attachment Plates
- Hanging Drop Plates
- 3D Bioreactors
- 3D Petri Dishes
- Microfluidics-based 3D Cell Cultures
- Magnetic & Bioprinted 3D Cell Cultures
Application Outlook (Revenue, USD Million, 2018 - 2028)
- Cancer & Stem Cell Research
- Drug Discovery & Toxicology Testing
- Tissue Engineering & Regenerative Medicine
End Use Outlook (Revenue, USD Million, 2018 - 2028)
- Pharmaceutical & Biotechnology Companies
- Research Institutes
- Cosmetics Industry
- Other End Users
Request for Custom Research @ https://www.reportsanddata.com/request-customization-form/3707
Regional Outlook (Revenue, USD Million, 2018 - 2028)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- BENELUX
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- U.A.E.
- South Africa
- Rest of MEA
Buy now your Exclusive copy of Report @ https://www.reportsanddata.com/checkout-form/3740
- Regional Outlook (Revenue, USD Billion; 2017-2027)
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- BENELUX
- Rest of Europe
- Asia Pacific
- China
- Japan
- South Korea
- Rest of APAC
- MEA
- Saudi Arabia
- UAE
- Rest of MEA
- Latin America
- Brazil
- Rest of LATAM
- North America
Explore Reports and Data’s Prime Analysis of the global Healthcare & Pharmaceutical Industry:
HLA Typing for Transplant Market Size, Share & Analysis, By Technology (Molecular Assays, Non-Molecular Assays), By Product (Instrument, Reagent, Software), By Application (Diagnostic, Research), By End-Use (Hospital, Diagnostic Labs, Academic & Research Institutes), And By Region, Forecast To 2028
Nucleic Acid Isolation and Purification Market Size, Share & Analysis, By Product (Kits & Reagent, Instrument), by Method (Column, Magnetic Beads, Others), By Type (Genomic DNA, Plasmid DNA, miRNA, Others), By Application (Drug Discovery & Development, Precision Medicine, Diagnostics, Others), By End-use Industry (Hospitals & Diagnostic Centers, Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, CROs, Others), and By Region, Forecast To 2028
Slide Stainers Market Size, Share & Analysis, By Product Type (Reagents, Consumables & Accessories, Equipment), By Technology (Immunohistochemistry, Hematoxylin And Eosin, In Situ Hybridization, Cytology, Hematology, Microbiology, Special Stains), By End-Use (Hospitals & Clinics, Diagnostic Centers, Pharmaceutical And Biotechnology Companies, Academic And Research Institutes, Others), And By Region Forecast To 2028
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.
Contact Us:
John W
Head of Business Development
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
Read Full Press Release: https://www.reportsanddata.com/press-release/global-3d-cell-culture-market